| BMC Research Notes | |
| Epidemiological, clinical features and susceptibility pattern of shigellosis in the buea health district, Cameroon | |
| Elroy P Weledji1  Maghah P Awafong3  Henri LF Kamga3  Dickson S Nsagha4  Jules CN Assob2  Anna L Njunda3  | |
| [1] Department of Clinical Sciences, Faculty of Health Sciences, University of Buea, P.O.Box 63, Buea, Cameroon;Medicine Programme, Department of Biomedical Sciences, Faculty of Health Sciences Laboratory, University of Buea, P.O.Box 63, Buea, Cameroon;Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Buea, P.O.Box 63, Buea, Cameroon;Department of Public Health and Hygiene, Faculty of Health Sciences, University of Buea, P.O.Box 63, Buea, Cameroon | |
| 关键词: Cameroon; Susceptibility pattern; Antibiotics; Clinical features; Epidemiology; Shigellosis; | |
| Others : 1166737 DOI : 10.1186/1756-0500-5-54 |
|
| received in 2011-09-27, accepted in 2012-01-21, 发布年份 2012 | |
PDF
|
|
【 摘 要 】
Background
Shigellosis is an acute invasive enteric infection caused by bacteria belonging to the genus Shigella; it is clinically manifested by bloody diarrhoea. Shigellosis is endemic in many developing countries including Cameroon and also occurs in epidemics causing considerable morbidity and mortality. This study evaluated the epidemiological and clinical features of Shigella and the resistance pattern of isolates to commonly used antibiotics in the Buea Health District in Cameroon, from April to August, 2010.
Results
Of the 223 stool samples cultured, 10 (4.5%) yielded Shigella species. Isolation rate was observed to be more in children below 15 years (7.89%), and also higher in rural areas (6.35%). All 10 isolates showed resistance to at least two antibiotics and 9 (90%) were multi-drug resistant. The highest resistance rates were encountered with cotrimoxazole (90%) and amoxicillin (80%). Least resistance was observed with azithromycin (10%).
Conclusion
Shigellosis is more prevalent in children below 15 years in the Buea District. There is a high level of resistance to most of the antibiotics used for the treatment of shigellosis including extended-spectrum beta-lactamases (ESBLs) as well as evidence of resistance to quinolones. Azithromycin was found to be the drug of choice for shigellosis in this setting.
【 授权许可】
2012 Njunda et al; licensee BioMed Central Ltd.
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| 20150416053451945.pdf | 227KB |
【 参考文献 】
- [1]Niyogi SK: Shigellosis. J Microbiol 2005, 43:33-43.
- [2]Watanabe T: Infective heredity of multiple drug resistance in bacteria. Bacteriology Review 1963, 27:87-115.
- [3]Sack BR, Rahman M, Yunus M, Khan HE: Antimicrobial resistance in organisms causing diarrheal disease. Clinical Infectious Disease 2007, 24:102-105.
- [4]Guyot A: Antibiotic resistance of Shigella in Monrovia, Liberia. Tropical Diseases 1969, 26:70-71.
- [5]Brito A, Nij B: Antibiotic resistance pattern and plasmid profiles for Shigella species isolated in Cordoba, Argentina. Antimicrob Agents and Chemotherapy 1994, 34:253-259.
- [6]Nguendo YB: Pathogenic microorganisms associated with childhood diarrhea in low and middle income countries: case study of Yaounde-Cameroon. Int J Environ Res Public Health 2008, 5:213-229.
- [7]Fotsing K: Etude sur la prévalence des différents agents pathogènes, bactériens chez les enfants de moins de 5 ans à Yaoundé. Colloque scientifique des Instituts Pasteur; 2001:239-244.
- [8]Gizachew Y, Challa N, Afework K: A five year antimicrobial resistance pattern observed in Shigella species isolated from stool samples in Gondar University Hospital, Northwest Ethiopia. Ethiopian J Health Development 2006, 20:194-198.
- [9]Patrick R, Muray S, Rosenthal K, Michael A: Medical miocrobiology. 5th edition. USA. Elsevier Mosby; 2002:323-333.
- [10]Taylor D, Echeverria P, Pal T: The role of Shigella spp., enteroinvasive Escherichia coli and other enteropathogens as causes of childhood dysentery in Thailand. J Infectious Diseases 2006, 153:1132-1138.
- [11]Pablo VE, Torres A, Freire JM, Hernandez V, Gil A: Factors associated to infant mortality in Sub-Saharan Africa. J Public Health In Africa 2011, 2:e27.
- [12]Levine MM: Shigellosis. In Strickland GT, Hunter's Tropical Medicine. 7th edition. Philadelphia WB Saunders Co; 2000:340-344.
- [13]World Health Organization: Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae 1. WHO Document Production Services, Geneva, Switzerland; 2005:1-64.
- [14]Neu H: The crisis in antibiotics resistance. J Science 1992, 257:1064.
- [15]Toukam M, Lyonga EE, Assoumou MCO, Fokunang CN, Atashili J, Kechia AF, Gonsu HK, Mesembe M, Eyoh A, Ikomey G, Akongnwi E, Ndumbe P: Quinolone and fluoroquinolone resistance in Enterobacteriaceae isolated from hospitalised and community patients in Cameroon. J Med Med Sci 2010, 1:490-494.
- [16]Belay R, Solomon W, Shiferaw T, Nina A: Antimicrobial susceptibility pattern of Shigella isolates in Awasa, Ethiopian. Ethiopian J Health and Dev 2000, 14:149-154.
- [17]Khan-Mohammed Z, Adesiyun AA, Swanston WH, Chadee DD: Frequency characteristics of selected enteropathogens in fecal and rectal specimens from childhood dirrhoea in Trinidad, 1998-2000. Rev Panam Salud Publica 2005, 17:170-177.
- [18]Tenover FC: Mechanisms of antimicrobial resistance in bacteria. Amer J Inf Control 2006, 34:S3-S10.
- [19]Rahbar M, Deldari M, Hajia M: Changing prevalence and antibiotic susceptibility patterns of different Shigella species in Teheran, Iran. The Internet J Microbiol 2007, 3:2.
- [20]Wilson G, Joshy ME, Chiranjoy M, Shivananda PG: Isolation and antimicrobial susceptibility of shigella from patients with acute gastroenteritis in western Nepal. Indian J Med 2006, 1:145-150.
- [21]Shah A, Hasan F, Ahmed S, Hameed A: Extended-Spectrum β-Lactamases (ESBLs): Characterization, Epidemiology and Detection. Critical Reviews in Microbiology 2004, 30:25-32.
- [22]Admoni O, Yagupsky P, Avivit G, Schifron G, Horowitz I: Epidemiological, Clinical and Microbiological Features of Shigellosis among Hospitalized Children in Northern Israel. Scand J Infect Dis 1995, 27:139-144.
- [23]Ruiz J: Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother 2003, 51:1109-1117.
- [24]Mensa L, Marco F, Vila J, Gasco J, Ruiz NJ: Quinolone resistance among Shigella spp. isolated from travellers returning from India. Clin Microbiol Infect 2008, 14:279-281.
- [25]Mache A: Antibiotic resistance and serogroups of Shigella among pediatric outpatients in Southwest Ethiopia. East African Medical J 2001, 78:6.
- [26]Assefa A, Gedlu E, Ashmelash T: Antibiotic resistance of prevalent Salmonella and Shigella strains in Northwest Ethiopia. East Afr Med J 2006, 74:36-41.
- [27]Murray BE: Resistance of Salmonella, Shigella and other selected enteric pathogens to antimicrobial agents. Infect Dis Rev 2002, 8:172-181.
- [28]Bopp CA, Brenner FW, Wells J, Strockbine NA: Escherichia, Shigella and Salmonella. In Manual of Clinical Microbiology. 7th edition. Edited by Murray PR, Pfaller MA, Tenover FC, Baron EJ, Yolken RH. Washington, DC: ASM Press; 2000:459-474.
- [29]Cheesbrough M: Antibiotic sensitivity testing, Enterobactereaceae. In Medical Laboratory Manual for tropical countries. Volume 2. Cambridge University Press; 2000::132-138. Microbiology EIBS pub. Low price Edition
- [30]Bauer AW, Kirby WW, Sheris JC, Tuek M: Antibiotic susceptibility testing by standardized single disc method. American J Clinical Pathology 1966, 36:493-496.
- [31]National Committee for Clinical Laboratory Standards: Performance standard for antimicrobial disk susceptibility tests: approved standards. 6th edition. Wayne; 2003. NCCLS document M2-A6
PDF